Emergent Biosolut…
USUSDEmergent Biosolutions Inc (US:EBS) — Biotechnology: Pharmaceutical Preparations. Количество бирж, на которых торгуются акции компании: 2. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О компании
- Сайт
- emergentbiosolutions.com
- Взаимодействие с инвесторами
- emergentbiosolutions.com/investors/
- Сектор
- Health Care · Biotechnology: Pharmaceutical Preparations
- Штаб-квартира
- Gaithersburg, United States
- Генеральный директор
- Mr. Joseph C. Papa Jr., M.B.A., R.Ph.
- Сотрудники
- 900
- Основана
- 1998
- Акций в обращении
- 51.27 млн на 2026-07-30
- Свободное обращение
- 49.07 млн
- Рыночная капитализация
- 354.81 млн USD
- Инсайдеры
- 4.26%
- Институциональные инвесторы
- 90.6%
- Отрасль (SIC)
- Pharmaceutical Preparations
- ISIN
- US29089Q1058
- LEI
- 549300YW6TUOX8BE5103
Описание
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Дивиденды
Выплаты дивидендов не обнаружены (проверено 09.10.2026). Компания, вероятно, не выплачивает дивиденды.
Новости этой недели
За последнюю неделю новостей нет. Последняя новость: 26.03.2026.
Крупнейшие держатели
| Держатель | Доля | Акции | Дата отчета |
|---|---|---|---|
| Blackrock Inc. | 9.2% | 4.72 млн | 2026-06-30 |
| Dimensional Fund Advisor… | 6% | 3.08 млн | 2026-06-30 |
| State Street Corporation | 5.71% | 2.93 млн | 2026-06-30 |
| American Century ETF Tru… | 5.44% | 2.79 млн | 2026-08-31 |
| American Century Compani… | 5.4% | 2.77 млн | 2026-06-30 |
| Vanguard Capital Managem… | 4.29% | 2.2 млн | 2026-06-30 |
| SPDR SERIES TRUST-State… | 3.51% | 1.8 млн | 2026-08-31 |
| LSV Asset Management | 3.31% | 1.7 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.03% | 1.55 млн | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.64% | 1.35 млн | 2026-07-31 |
| Acadian Asset Management… | 2.62% | 1.34 млн | 2026-06-30 |
| Geode Capital Management… | 2.61% | 1.34 млн | 2026-06-30 |
| Charles Schwab Investmen… | 2.34% | 1.2 млн | 2026-06-30 |
| Oak Hill Advisors, L.P. | 2.17% | 1.11 млн | 2026-06-30 |
| SCHWAB STRATEGIC TRUST-S… | 1.48% | 757 640 | 2026-05-31 |
| DFA INVESTMENT DIMENSION… | 1.38% | 705 560 | 2026-07-31 |
| Federated Hermes MDT Ser… | 1.23% | 630 315 | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.16% | 592 784 | 2026-06-30 |
| Fidelity Salem Street Tr… | 1.11% | 569 090 | 2026-07-31 |
| VANGUARD HORIZON FUNDS-V… | 1.03% | 528 566 | 2026-06-30 |
| PAPA JOSEPH C (Chief Exe… | ≈0.96% | 493 153 | 2026-04-29 |
| LINDAHL RICHARD S (Chief… | ≈0.74% | 378 047 | 2026-04-29 |
| GLESSNER COLEEN (Officer… | ≈0.4% | 204 219 | 2026-04-29 |
| HARTZEL WILLIAM (Officer… | ≈0.37% | 187 299 | 2026-04-29 |
| LOWRY SIMON C (Officer) | ≈0.35% | 177 914 | 2026-04-29 |
| PERL JESSICA (General Co… | ≈0.32% | 165 286 | 2026-04-29 |
| FOWLER NEAL FRANKLIN (Di… | ≈0.31% | 160 847 | 2026-04-30 |
| WILLIAMS PAUL ANTHONY (O… | ≈0.31% | 159 098 | 2026-07-01 |
| HARSANYI ZSOLT (Chairman… | ≈0.29% | 149 076 | 2026-04-30 |
| SULLIVAN LOUIS W (Direct… | ≈0.27% | 139 098 | 2025-04-30 |
